In a CRISPR first, recently discovered protein has been found to act as a kind of multipurpose self-destruct system for bacteria.

For years, scientific estimates of when the smallpox virus first emerged have been at odds with historical records.

A new technology enables the body to produce therapeutic agents on demand at the exact location where they are needed.

Multiple sclerosis, a progressive disease that affects 2.8 million people worldwide has no definitive cure and is likely caused by infection

A study by MIT researchers finds that indoor relative humidity may also influence transmission of the COVID-19 virus.

A compound that both inhibits the MRSA superbug and renders it more vulnerable to antibiotics has been discovered by scientists.

International team of researchers has identified DNA mutations in a gene that senses viral RNA, as a cause of the autoimmune disease lupus.

A highly efficient LED could one day help countries emerge from the shadows of pandemics by killing pathogens in rooms full of people.

University of Queensland virologists are a step closer to understanding a mysterious AIDS-like virus that is impacting koala populations.

A common respiratory virus, called adenovirus, to act like a Trojan horse to deliver genes for cancer therapeutics directly into tumor cells

Scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine.

A highly efficient LED that is deadly to microbes and viruses but safe for people has been engineered by three RIKEN physicists.

Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure.

How can we selectively kill harmful gut bacteria that cause inflammatory bowel disease or other disorders? Researchers suggest using viruses

A highly efficient LED that is deadly to microbes and viruses but safe for people has been engineered by three RIKEN physicists.

Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure.

Scientists have modified a common respiratory virus, called adenovirus, to act like a Trojan horse to deliver genes for cancer therapeutics.

Two studies from Scripps Research combine bioinformatics and other techniques to develop new vaccine candidates against HIV.

The Australian analysis found that individuals with T1D were eight times more likely to have an enterovirus infection than those without T1D

A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.